These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8336496)

  • 1. Summary of a blind quality assurance program for urinalysis.
    Dyszel SM; Erikson CM; Hood LV
    J Anal Toxicol; 1993; 17(3):190-1. PubMed ID: 8336496
    [No Abstract]   [Full Text] [Related]  

  • 2. Is quantitative urinalysis more sensitive?
    Li SH; Chiang N; Tai B; Marschke CK; Hawks RL
    NIDA Res Monogr; 1997; 175():265-86. PubMed ID: 9467804
    [No Abstract]   [Full Text] [Related]  

  • 3. Urine drug screens.
    Cockrell K
    Indiana Med; 1991 Jun; 84(6):416-7. PubMed ID: 1918913
    [No Abstract]   [Full Text] [Related]  

  • 4. I Have Never Used Methamphetamine, But My Urinalysis Says I Do.
    Sethi R; Din A; McAllister R; Lester A
    Prim Care Companion CNS Disord; 2018 Oct; 20(5):. PubMed ID: 30407755
    [No Abstract]   [Full Text] [Related]  

  • 5. A tale of two drug testing technologies: GC-MS and LC-MS/MS.
    Mikel C; Pesce A; West C
    Pain Physician; 2010; 13(1):91-2. PubMed ID: 20119467
    [No Abstract]   [Full Text] [Related]  

  • 6. How can the clinical picture guide appropriate laboratory drug testing in the treatment of pain clinic patients with opioid analgesics?
    Abadie J
    Pain Med; 2012 Jul; 13(7):857-9. PubMed ID: 22804904
    [No Abstract]   [Full Text] [Related]  

  • 7. 3 things to consider before relying solely on point of care tests for determining benzodiazepine use in chronic pain.
    Mikel C; Pesce A; West C
    Pain Physician; 2012; 15(2):E154-5; author reply E155-6. PubMed ID: 22430663
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urine testing in the treatment of opiate addiction].
    Ege PP
    Ugeskr Laeger; 2003 Mar; 165(13):1346-8. PubMed ID: 12703279
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of thin-layer chromatography methods for laxative detection.
    Duncan A; Phillips IJ
    Ann Clin Biochem; 2001 Jan; 38(Pt 1):64-6. PubMed ID: 11270846
    [No Abstract]   [Full Text] [Related]  

  • 10. Ethical perspectives on urine drug screening for pain physicians.
    Kaye AD; Marshall ZJ; Lambert SM; Trescot AM; Prabhakar A; Elhassan AO; Urman RD
    Pain Physician; 2014; 17(5):E559-64. PubMed ID: 25247905
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferences with urine drug screens.
    Herring C; Muzyk AJ; Johnston C
    J Pharm Pract; 2011 Feb; 24(1):102-8. PubMed ID: 21507878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky.
    Gilbert JW; Wheeler GR; Mick GE; Storey BB; Herder SL; Richardson GB; Watts E; Gyarteng-Dakwa K; Marino BS; Kenney CM; Siddiqi M; Broughton PG
    Pain Physician; 2010; 13(2):167-86. PubMed ID: 20309383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of quality assurance in testing drugs of abuse.
    Ferrara SD
    Forensic Sci Int; 1993 Dec; 63(1-3):305-9. PubMed ID: 8138231
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of fluid load on human urine characteristics related to workplace drug testing.
    Chaturvedi AK; Sershon JL; Craft KJ; Cardona PS; Soper JW; Canfield DV; Dubowski KM; Whinnery JE; Leyva MJ; Aston CE; Blevins SM; Wright JE; Fraser AD; Kuntz DJ
    J Anal Toxicol; 2013; 37(1):5-10. PubMed ID: 23104711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Accreditation should be discussed! Need for substance abuse testing at the workplace should be increased].
    Beck O; Hjemdahl P
    Lakartidningen; 1998 Jan; 95(5):407-8. PubMed ID: 9492489
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimation of Measurement Uncertainty in Quantitation of Benzoylecgonine (BZE) and 11-nor-Δ9-THC-9-carboxylic acid (THCA).
    Arfsten DP; Roman Perez E; Goebel NC
    J Anal Toxicol; 2018 Apr; 42(3):141-148. PubMed ID: 29351661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results.
    Crouch DJ; Cheever ML; Andrenyak DM; Kuntz DJ; Loughmiller DL
    J Forensic Sci; 1998 Jan; 43(1):35-40. PubMed ID: 9456522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug abuse tests important part of preventive measures against narcotics. With testing drug abuse can be identified early in the workplace].
    Hermansson U; Beck O; Westregård A; Brunes M
    Lakartidningen; 2010 Nov 17-23; 107(46):2878-80. PubMed ID: 21197782
    [No Abstract]   [Full Text] [Related]  

  • 19. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Unexpected Urine Test: A Matter Far From Simple.
    Kertesz SG
    J Addict Med; 2017; 11(6):417-419. PubMed ID: 28953503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.